Fundz

Fundz Deep Dive

Everything you need to win Army — in one platform.

Who to reach, what to say, and why now on Army — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Army — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Judge denies protests over $10B Army IT hardware contract

Feb 05, 2025•over 1 year ago

Contract Type

contract

BiotechnologyHealth CareVenture Capital

Description

A federal judge has denied protests from multiple companies regarding their removal from the competition for a $10 billion Army IT product contract. The judge's ruling ended the pre-award protests and confirmed the Army's decision to make up to 17 awards for the 10-year vehicle.

Company Information

Company

Army

About

The Cardiff Advisory Managing Partner has decades of experience guiding life sciences and healthcare companies through significant growth, has won the Alzheimer's Association of San Diego 2023 Hope Award and has been named among San Diego's 500 Most Influential People for the past four years. Recognized as one. David H. Crean, Ph.D., is a seasoned leader with over three decades of extensive experience in mergers and acquisitions, strategic partnerships and investments in the dynamic sectors of life sciences and health care. His expertise spans a variety of roles across leading biopharmaceutical institutions, investment banking and the venture capital and private equity landscape. At the helm of Cardiff Advisory LLC as Managing Partner, Dr. Crean runs a boutique firm that specializes in M&A, strategic advisory services and investment banking, serving life sciences and business clients through significant growth and exit strategies. Focuses on guiding healthcare companies. Senna Biosciences, Inc. is a private biopharmaceutical company in La Jolla, California, entering the clinical phase. The company focuses on the discovery and development of innovative medicines for the prevention and treatment of Alzheimer's disease. Senna has a transformative, innovative and differentiated patented technology that targets the underlying cause of disease and addresses previous failures by others. IND filing of Senna's first-in-class peptide drug is planned within the next few months.

Predictive Intelligence
Strategic

ML-powered predictions for Army's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.